Showing results (21-30 of 13,583) with videos related to
Sort By:
Pageof 1,359
Atherosclerosis|February 1, 1992
High density lipoproteins: physiopathology and clinical relevanceA Corsini, F Bernini, C Vergani, et al.Atherosclerosis|March 1, 1992
Low density lipoprotein ligand-receptor interactions in normal healthy individuals characterized by their XbaI apolipoprotein B DNA polymorphismE Vilella, J Balanyà, L Masana, et al.Atherosclerosis|February 12, 2011
Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly ChineseYu Xu, Min Xu, Yufang Bi, et al.Atherosclerosis|January 21, 2011
Macrophages exposed to hypoxia secrete proteoglycans for which LDL has higher affinityAnnika Asplund, Vincent Fridén, Pia Stillemark-Billton, et al.Atherosclerosis|November 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response studyD B Hunninghake, R H Knopp, G Schonfeld, et al.Atherosclerosis|August 1, 1978
Hypercholesterolemia in renal allograft recipients. Comparison with non-renal hypercholesterolemia and normal subjectsJ B Somer, L K Abbott, C Elliott, et al.Atherosclerosis|September 1, 1978
Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemiaP Weisweiler, P SchwandtAtherosclerosis|September 1, 1978
Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatmentL A Carlson, G WahlbergAtherosclerosis|August 1, 1990
Oxidation of cholesteryl linoleate by human monocyte-macrophages in vitroK L Carpenter, J A Ballantine, B Fussell, et al.Atherosclerosis|July 1, 1990
Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramineM Shiomi, T Ito, Y Watanabe, et al.Pageof 1,359